Browse Studies — Arctuva

Observational

Impact of Routine Electronic Patient-Reported Outcome (ePRO)Symptom Monitoring During Neoadjuvant Therapy in Patients withPancreatic Adenocarcinoma on Patient Experience and ClinicalOutcomes: A Prospective Pre-Post Implementation Study

To learn if routine symptom monitoring using questionnaires during chemotherapy and/or radiation therapy in patients with PDAC improves patient health-related …

ePROSymptom MonitoringNeoadjuvant Therapy+2 more

Estimated

~$10 – $750

Actual pay is set by the research site.

Find your next paid study

Impact of Routine Electronic Patient-Reported Outcome (ePRO)Symptom Monitoring During Neoadjuvant Therapy in Patients withPancreatic Adenocarcinoma on Patient Experience and ClinicalOutcomes: A Prospective Pre-Post Implementation Study

Prospective Evaluation of Temporal Clinical Dynamics, Physiologic Trajectories, and Time-Dependent Digital Biomarkers for Prediction of Clinically Meaningful Patient Outcomes